Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
Clinical trial NCT04247074 · COMPLETED
Trial details
- NCT number
- NCT04247074
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2020-10-02
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.